Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
In the case of COPD, mesenchymal stem cells (MSCs) derived from umbilical cord tissue or other sources have been studied extensively for their ability to: Reduce inflammation in the lungs Repair damaged alveoli (air sacs) that help with oxygen exchange Improve lung function by promoting tissue regeneration Enhance overall immune system balance What the Science Says Several studies highlight the effectiveness of stem cell therapy in COPD: A 2017 clinical trial published in Respiratory Research found that intravenous administration of mesenchymal stem cells in COPD patients was safe and led to reduced systemic inflammation (Weiss et al., 2017)
Read all patient information, medication guides, or drug information sheets that come with this medication
What are sulfur burps, and why do they happen
Injection technique significantly influences tolerability
Real Styku scans from completed programs show: Patient Example 1 - Female, 53 years old: Lost 21 pounds total Lost 6 pounds of visceral fat Lost 5.4% body fat Gained 5.1% muscle Patient Example 2 - Female, 45 years old: Lost 23 pounds total Lost 3 pounds of visceral fat Lost 9 pounds of gynoid fat Lost 4.2% body fat Gained 3.9% muscle Patient Example 3 - Female, 26 years old: Lost 16 pounds total Lost 9.7% body fat Gained 9.2% muscle These results demonstrate true body transformationnot just water weight or muscle loss, but actual fat reduction combined with muscle preservation and growth
